9 Meters Biopharma Inc. (NMTRQ)
OTCMKTS: NMTRQ · Delayed Price · USD
0.00
0.00 (0.00%)
Jul 2, 2024, 4:00 PM EDT - Market closed
9 Meters Biopharma Market Cap
9 Meters Biopharma has a market cap or net worth of $1.45 thousand as of July 2, 2024. Its market cap has decreased by -100.00% in one year.
Market Cap
1.45K
Enterprise Value
-2.52M
1-Year Change
-100.00%
Ranking
n/a
Category
Stock Price
n/a
Market Cap Chart
Since July 8, 2016, 9 Meters Biopharma's market cap has decreased from $28.20M to $1.45K, a decrease of -99.99%. That is a compound annual growth rate of -75.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2023 | 1.00M | -93.87% |
| Dec 30, 2022 | 16.30M | -93.49% |
| Dec 31, 2021 | 250.20M | 93.80% |
| Dec 31, 2020 | 129.10M | 545.50% |
| Dec 31, 2019 | 20.00M | -66.78% |
| Dec 31, 2018 | 60.20M | 956.14% |
| Dec 29, 2017 | 5.70M | -55.47% |
| Dec 30, 2016 | 12.80M | -54.61% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 860.48B |
| Novo Nordisk | 629.27B |
| UnitedHealth Group | 468.72B |
| Johnson & Johnson | 351.76B |
| Merck & Co. | 313.56B |
| AbbVie | 302.88B |
| AstraZeneca | 241.81B |
| Thermo Fisher | 211.09B |